Skip to main content
Fig. 7 | BMC Complementary Medicine and Therapies

Fig. 7

From: Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches

Fig. 7

Real time-PCR analysis for epigenetic-related genes [DNA methyltransferase (DNMT3B), histone deacetylase (HDAC3) and miRNA-29c] after thymoquinone (TQ), piperine (PIP), and sorafenib (SOR) treatments for 48 hs in HepG2 (A-C) and MDA-MB-231 (D-F) cells. The data provided are mean ± SEM (n = 3). Means within columns carrying * are significantly different at (p ˂0.05), ** (p ˂ 0.01), *** (p ˂ 0.001) and **** (p ˂ 0.0001)

Back to article page